comparemela.com

Latest Breaking News On - இயக்குனர் ராகேஷ் மிஸ்ரா - Page 2 : comparemela.com

ड्राई स्वैब आरटी-पीसीआर टेस्ट उपयोग के लिए स्वीकृत

ड्राई स्वैब आरटी-पीसीआर टेस्ट उपयोग के लिए स्वीकृत
webdunia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webdunia.com Daily Mail and Mail on Sunday newspapers.

DCGI approves anti-cancer drug Wincov-19 on the lines of anti-venom | एंटी वेनम की तर्ज पर बनी एंटी काेराेना दवा विनकोव-19 को डीसीजीआई से मिली मंजूरी

DCGI approves anti-cancer drug Wincov-19 on the lines of anti-venom | एंटी वेनम की तर्ज पर बनी एंटी काेराेना दवा विनकोव-19 को डीसीजीआई से मिली मंजूरी
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.

covishield effective against double mutant variant First study found

covishield effective against double mutant variant First study found
jagran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagran.com Daily Mail and Mail on Sunday newspapers.

Coronavirus | Genomic surveillance of SARS-CoV-2 hit by shortage in samples from patients

Updated: April 21, 2021 17:07 IST CCMB and Centre for DNA Fingerprinting and Diagnostics (CDFD) are among the 10 labs chosen by the Centre for genome sequencing of the COVID-19 samples Share Article AAA File photo shows a 3D print of a spike protein of SARS-CoV-2 in front of a 3D print of a SARS-CoV-2 virus particle. Photo: NIH/NIAD-RML via AFP   CCMB and Centre for DNA Fingerprinting and Diagnostics (CDFD) are among the 10 labs chosen by the Centre for genome sequencing of the COVID-19 samples It has been three months since the formation of the Indian SARS-CoV-2 Genomics Consortium (INSACOG). It is comprised of top 10 regional labs of CSIR, DBT and ICMR and is involved in genomic surveillance of SARS-CoV-2. However, they are yet to get sufficient number of samples from the COVID-19 positive patients from both government and private healthcare centres.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.